S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia

Completed · Phase 2

Conditions studied: Leukemia

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of 506U78 in treating patients who have recurrent or refractory acute lymphocytic leukemia.

Key facts

Study ID
NCT00006020
Run by
SWOG Cancer Research Network
People needed
35
Starts
2000-07-01
Expected to finish
2004-07-01
Last updated by the study team
2015-03-06

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.